Gilbert R W, Birt D, Shulman H, Freeman J, Jenkin D, MacKenzie R, Smith C
Department of Otolaryngology, Toronto-Bayview Regional Cancer Centre, University of Toronto, Ontario, Canada.
Ann Otol Rhinol Laryngol. 1987 Sep-Oct;96(5):514-8. doi: 10.1177/000348948709600507.
An analysis of 37 patients with laryngeal carcinoma (T2 or greater) treated with radical radiotherapy, with surgery reserved for failure, was performed to determine if tumor volume, alone or in association with other prognostic factors, accurately predicted the probability of local control. Patient records were reviewed retrospectively and the following data extracted: age, sex, laryngeal region and number of sites involved by tumor, T and N categories, and success or failure of radiotherapy. Tumor volume for each patient was calculated from pretreatment computed tomograms by summing the products of the cross-sectional tumor area on each CT cut and the interval in millimeters between sequential CT cuts. The mean tumor volume for patients failing radiotherapy was 21.8 cm3, and the mean volume for patients primarily controlled by radiotherapy was 8.86 cm3. Tumor volume significantly predicted disease-free interval (p = .045) and outcome with radiotherapy (p = .02). The study suggests that tumor volume is a significant factor in determining the outcome of primary radiotherapy in advanced laryngeal carcinoma.
对37例喉癌(T2期或更晚期)患者进行了分析,这些患者接受了根治性放疗,仅在放疗失败时才进行手术,目的是确定肿瘤体积单独或与其他预后因素联合起来能否准确预测局部控制的概率。对患者记录进行了回顾性审查,并提取了以下数据:年龄、性别、喉区及肿瘤累及部位数量、T和N分期以及放疗的成功或失败情况。通过将每个CT层面上肿瘤的横截面积与相邻CT层面之间的毫米间距相乘后求和,根据治疗前的计算机断层扫描计算出每位患者的肿瘤体积。放疗失败患者的平均肿瘤体积为21.8 cm³,而放疗后病情得到初步控制的患者的平均体积为8.86 cm³。肿瘤体积显著预测了无病间期(p = 0.045)和放疗结果(p = 0.02)。该研究表明,肿瘤体积是决定晚期喉癌初次放疗结果的一个重要因素。